General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
Innovative technological advancements drive growth in the neuromodulation market. Extended battery lifespans, directional leads and higher frequency stimulation have all been incorporated in recent years. Regulatory issues may limit growth in the intrathecal pump market over the next years as two leading competitors face challenges. Flowonix had the CE mark for its pump suspended in 2016. Medtronic faces an FDA consent decree and regulators in the U.K. recently published a report on specific issues with device functioning. A major emerging trend in the neurological market is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.
'
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 55
4.1 INTRODUCTION 55
4.1.1 Cerebrospinal Fluid Management 55
4.1.2 Interventional Neuroradiology 56
4.1.3 Neuromodulation 57
4.1.4 Neurosurgery 57
4.1.5 Mechanical Thrombectomy 58
4.1.6 Transcranial Magnetic Stimulators 58
4.2 CURRENCY EXCHANGE RATE 59
4.3 MARKET OVERVIEW 60
4.4 TREND ANALYSIS BY SEGMENT 68
4.5 DRIVERS AND LIMITERS 73
4.5.1 Market Drivers 73
4.5.1.1 Cerebrospinal Fluid Management 73
4.5.1.2 Interventional Neuroradiology 73
4.5.1.3 Neuromodulation 74
4.5.1.4 Neurosurgery 76
4.5.1.5 Mechanical Thrombectomy 76
4.5.1.6 Transcranial Magnetic Stimulator 77
4.5.2 Market Limiters 77
4.5.2.1 Cerebrospinal Fluid Management 77
4.5.2.2 Interventional Neuroradiology 78
4.5.2.3 Neuromodulation 79
4.5.2.4 Neurosurgery 80
4.5.2.5 Mechanical Thrombectomy 81
4.5.2.6 Transcranial Magnetic Stimulator 82
4.6 COMPETITIVE MARKET SHARE ANALYSIS 85
ABBREVIATIONS 100
APPENDIX: COMPANY PRESS RELEASES 103
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 4 1: Neurological Device Market by Segment, Europe, 2013 – 2023 66
Chart 4 2: Neurological Device Market Breakdown, Europe, 2016 67
Chart 4 3: Neurological Device Market Breakdown, Europe, 2023 67
Chart 4 4: Growth Rates by Segment, Neurological Device Market, Europe, 2013 – 2023 72
Chart 4 5: Leading Competitors, Neurological Device Market, Europe, 2016 95
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Currency Exchange Rate, 2016 59
Figure 4 2: Total Neurological Device Market, Europe, 2013 – 2023 (€M) 61
Figure 4 3: Total Neurological Device Market, Europe, 2013 – 2023 (US$M) 61
Figure 4 4: Neurological Device Market by Segment, Europe, 2013 – 2023 (€M) (1 of 2) 62
Figure 4 5: Neurological Device Market by Segment, Europe, 2013 – 2023 (€M) (2 of 2) 63
Figure 4 6: Neurological Device Market by Segment, Europe, 2013 – 2023 (US$M) (1 of 2) 64
Figure 4 7: Neurological Device Market by Segment, Europe, 2013 – 2023 (US$M) (2 of 2) 65
Figure 4 8: Neurological Device Market Growth by Segment, Europe, 2013 – 2023 (1 of 2) 70
Figure 4 9: Neurological Device Market Growth by Segment, Europe, 2013 – 2023 (2 of 2) 71
Figure 4 10: Market Drivers, Neurological Device Market, Europe, 2016 83
Figure 4 11: Market Limiters, Neurological Device Market, Europe, 2016 84
Figure 4 12: Leading Competitors, Neurological Device Market, Europe, 2016 (1 of 4) 91
Figure 4 13: Leading Competitors, Neurological Device Market, Europe, 2016 (2 of 4) 92
Figure 4 14: Leading Competitors, Neurological Device Market, Europe, 2016 (3 of 4) 93
Figure 4 15: Leading Competitors, Neurological Device Market, Europe, 2016 (4 of 4) 94
Figure 6 1: Press Release Summary 103
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
